United States · Funded startup

Who invested in Kaida BioPharma

2 rounds we have observed, with the 0 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Raised 2 months ago

Funding summaryUpdated 15 Nov 2026

$3.2Mraised across 2 rounds since 2026, from 2 sources

$1.6MRound$1.6MRound
Latest round
Round, $1.6MSept 2026
Investors
0
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20262027
$1.6MRound$1.6MRound
First round
Round, $1.6M
Jan 2026
Biggest round
$1.6M
Round · Sept 2026
Between rounds
7 months
from the last two

The rounds

  1. Sept 2026
    Round$1.6M

    No investor was named in the report.

    Filed with the SEC (Form D); no report of this raise yetSEC filing: $1.6M sold, first sale Sept 2026

  2. Jan 2026
    Round$1.6M

    No investor was named in the report.

    Filed with the SEC (Form D); no report of this raise yetSEC filing: $1.6M sold, first sale Jan 2026

Funding filed with regulators

Kaida BioPharma filed 3 raises, $3.2M in all. Filings say how much was sold and to how many investors; they never name the investors.

  1. Sept 2026$1.6M44 investorsof $4.1M offeredSEC Form D
  2. Jan 2026$1.6M42 investorsof $3.0M offeredSEC Form D
  3. Jun 2023$4K47 investorsequitySEC Form D

Quick answers about Kaida BioPharma

How much has Kaida BioPharma raised?

Kaida BioPharma has raised $3.2M across 2 rounds since 2026.

When did Kaida BioPharma last raise?

Kaida BioPharma's most recent round, $1.6M, was in Sept 2026.

What was Kaida BioPharma's biggest round?

Its most recent round, $1.6M in Sept 2026, is also its largest on record.

Where is Kaida BioPharma based?

Kaida BioPharma is based in the United States.

Companies like Kaida BioPharma

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.